Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, July 11-13, 2022
12 juil. 2022 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD., July 12, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage biopharmaceutical company developing drugs to improve...